ORMD-0801 QD
ORA-D-N01B
Phase 2 small_molecule completed
Quick answer
ORMD-0801 QD for Nonalcoholic Steatohepatitis (NASH) is a Phase 2 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ORAMED PHARMACEUTICALS INC.
- Indication
- Nonalcoholic Steatohepatitis (NASH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed